Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 331 followers

Latest posts

Last updated about 3 hours ago

Human medicines European public assessment report (EPAR): Nuwiq, simoctocog alfa, Date of authorisation: 22/07/2014, Revision: 14, Status: Authorised

about 5 hours ago

Human medicines European public assessment report (EPAR): Nuwiq, simoctocog alfa, Date of...

Human medicines European public assessment report (EPAR): Zoledronic acid Teva, zoledronic acid, Date of authorisation: 16/08/2012, Revision: 16, Status: Authorised

about 5 hours ago

Human medicines European public assessment report (EPAR): Zoledronic acid Teva, zoledronic acid...

Human medicines European public assessment report (EPAR): Bavencio, avelumab, Date of authorisation: 18/09/2017, Revision: 23, Status: Authorised

about 5 hours ago

Human medicines European public assessment report (EPAR): Bavencio, avelumab, Date of authorisation...

Scientific advice and protocol assistance adopted during the CHMP meeting 20-23 April 2026

about 5 hours ago

Scientific advice and protocol assistance adopted during the CHMP meeting 20-23 April...

Human medicines European public assessment report (EPAR): Exjade, deferasirox, Date of authorisation: 28/08/2006, Revision: 58, Status: Authorised

about 6 hours ago

Human medicines European public assessment report (EPAR): Exjade, deferasirox, Date of authorisation...

Human medicines European public assessment report (EPAR): Ceprotin, human protein C, Date of authorisation: 16/07/2001, Revision: 21, Status: Authorised

about 6 hours ago

Human medicines European public assessment report (EPAR): Ceprotin, human protein C, Date...

List of eligible industry stakeholder organisations

about 6 hours ago

List of eligible industry stakeholder organisations

Human medicines European public assessment report (EPAR): Kisqali, ribociclib, Date of authorisation: 22/08/2017, Revision: 26, Status: Authorised

about 6 hours ago

Human medicines European public assessment report (EPAR): Kisqali, ribociclib, Date of authorisation...

EMA closed on Whit Monday, 25 May

about 6 hours ago

EMA closed on Whit Monday, 25 May